ClinicalTrials.Veeva

Menu

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

University of Florida logo

University of Florida

Status

Enrolling

Conditions

Weight Loss
Diabetes

Treatments

Procedure: Anterior Vagotomy
Behavioral: tVNS
Procedure: Complete Vagotomy

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT06861790
R01DK099334 (U.S. NIH Grant/Contract)
IRB202301845

Details and patient eligibility

About

The goal of the study to understand the effects of weight loss and improvements in diabetes following bariatric surgery on brain function and thinking. This study will also examine whether non-invasive transcutaneous vagal nerve stimulation (tVNS) intervention initiated 30 days post-surgery improves brain function and thinking. The study does NOT cover any costs associated with bariatric surgery.

Full description

There will be one group of study participants.

The group will (independently of this research study) have weight loss surgery to help them with weight loss.

All research participants in this group will be tested on thinking and memory processes at the start of the study, after 12 weeks, and again at 18 months. They will also undergo a non-invasive transcutaneous vagal nerve stimulation (tVNS) intervention days post-surgery, for 30 days at home with the device that is provided.

The group will have an MRI Brain Scan at each time-point to study the changes in the structure and function of the brain tissue.

Blood tests will be done to measure the sugar levels in the blood, and other proteins that may act as markers for disease.

Enrollment

120 estimated patients

Sex

All

Ages

20 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Between age: 20-75 yrs, English speaking, Physically mobile
  • Body Mass Index (BMI) >35 kg before surgery
  • Compatible of MRI Scanning
  • Willing to give a small blood sample
  • Capable of providing informed consent

Exclusion criteria

  • Prior or current neurological disorder
  • Major psychiatric disturbance
  • Unstable medical conditions (cancer)
  • MRI contraindications (claustrophobia, metal implants, waist/torso circumference)

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

120 participants in 4 patient groups

tVNS + anterior vagotomy
Experimental group
Description:
This arm will receive transcutaneous vagus nerve stimulation and an anterior vagotomy during their bariatric surgery. Note a vagotomy is standard practice during bariatric surgery.
Treatment:
Behavioral: tVNS
Procedure: Anterior Vagotomy
tVNS + complete vagotomy
Experimental group
Description:
This arm will receive transcutaneous vagus nerve stimulation and a complete vagotomy during their bariatric surgery. Note a vagotomy is standard practice during bariatric surgery
Treatment:
Procedure: Complete Vagotomy
Behavioral: tVNS
Sham + anterior vagotomy
Sham Comparator group
Description:
This arm will not receive transcutaneous vagus nerve stimulation and will receive an anterior vagotomy during their bariatric surgery. Note a vagotomy is standard practice during bariatric surgery.
Treatment:
Procedure: Anterior Vagotomy
Sham + complete vagotomy
Sham Comparator group
Description:
This arm will not receive transcutaneous vagus nerve stimulation and will receive a complete vagotomy during their bariatric surgery. Note a vagotomy is standard practice during bariatric surgery.
Treatment:
Procedure: Complete Vagotomy

Trial contacts and locations

1

Loading...

Central trial contact

Ronald Cohen, PhD; Keyanni J Johnson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems